Table 3.
Joint cross-sectional association of sleep hours and insomnia with metabolic syndrome and its components at baseline in a sample of women from the Women’s Health Initiative using logistic regression models
| MetS | Waist > 88 cm | Hypertension | Fasting glucose ≥ 100 mg/dL | HDL < 50 mg/dL | Triglycerides ≥ 150 mg/dL | |||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sleep Duration (hours) | No Insomnia | Insomnia | No Insomnia | Insomnia | No Insomnia | Insomnia | No Insomnia | Insomnia | No Insomnia | Insomnia | No Insomnia | Insomnia |
| OR (95%CI) | OR (95%CI) | OR (95%CI) | OR (95%CI) | OR (95%CI) | OR (95%CI) | OR (95%CI) | OR (95%CI) | OR (95%CI) | OR (95%CI) | OR (95%CI) | OR (95%CI) | |
| < 6 | 1.07 (0.79–1.47) | 1.03 (0.79–1.33) | 0.97 (0.71–1.32) | 1.20 (0.94–1.54) | 0.92 (0.68–1.24) | 1.01 (0.79–1.29) | 1.38 (1.00–1.90) | 1.16 (0.89–1.51) | 1.03 (0.74–1.42) | 0.87 (0.67–1.13) | 1.02 (0.74–1.41) | 1.06 (0.82–1.36) |
| 6- < 7 | 0.98 (0.81–1.19) | 1.20 (0.98–1.49) | 1.03 (0.88–1.27) | 1.31 (1.06–1.61) | 0.97 (0.81–1.16) | 1.01 (0.82–1.25) | 1.01 (0.83–1.23) | 1.13 (0.90–1.43) | 1.02 (0.84–1.24) | 1.01 (0.80–1.24) | 0.94 (0.78–1.13) | 1.16 (0.92–1.43) |
| 7- < 8 | ref | 1.22 (0.95–1.56) | ref | 1.17 (0.92–1.48) | ref | 1.08 (0.85–1.36) | ref | 1.36 (1.05–1.76) | ref | 1.09 (0.85–1.41) | ref | 1.10 (0.87–1.40) |
| 8- < 9 | 1.12 (0.92–1.35) | 1.26 (0.86–1.84) | 1.21 (1.01–1.57) | 1.37 (0.95–1.99) | 0.89 (0.74–1.06) | 1.10 (0.77–1.59) | 1.04 (0.85–1.28) | 1.24 (0.83–1.84) | 0.93 (0.76–1.14) | 1.23 (0.83–1.81) | 1.21 (1.01–1.46) | 1.53 (1.06–2.20) |
| ≥ 9 | 1.54 (1.03–2.00) | 2.89 (1.39–6.01) | 1.42 (1.02–1.98) | 1.83 (0.87–3.86) | 1.30 (0.94–1.84) | 1.51 (0.71–3.24) | 1.18 (0.82–1.68) | 1.33 (0.61–2.91) | 1.21 (0.85–1.72) | 1.98 (0.79–3.57) | 1.47 (1.04–2.03) | 1.35 (0.54–3.41) |
Abbreviations: MetS Metabolic syndrome, HDL high density lipoproteins, OR Odds ratio, CI Confidence interval, ref reference group
Models adjusted for age, ethnicity, educational level, study participation, hormone therapy ever, smoking status, pack-years of smoking, alcohol intake, physical activity, coffee intake, depression, age at menopause and marital status (see Table 2 for details)